| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |